Doing Some Microscopic Research On Mushrooms? This Company Is Offering Psilocybin Spores

Denver-based Shaman Mushroom Spores is offering high-quality psilocybe cubensis mushroom spore syringes exclusively available for research purposes.

See also: Link Between Cancer And Psilocybin: Research On This Palliative Promise

The business was founded to obtain psilocybin spores for microscopy research purposes, each syringe containing hundreds of thousands of mushroom spores (each black dot visible with the naked eye is actually a cluster of hundreds of spores.)

See also: Psychedelics In Colorado: Gov Ratifies Bill, Report Shows No Increase In Public Health Harms

“Our mushroom spore syringes are lab-tested and quality-controlled, assuring researchers and customers the highest possible purity standards,” said a company spokesperson. “With the study of psilocybin mushrooms now in its renaissance, we pride ourselves on our meticulous microscopic research, offering quality that exceeds industry standards.”

See also: Magic Mushroom Microdosing: Why The Trend Is Catching On And What The Practice Is All About

The past years show an increasing amount of research on classical psychedelics, including psilocybin mushrooms, with sound evidence on this substance’s beneficial effects over a wide array of mental health conditions including addictions and depression, with potential long-term advantages. 

See also: Tryp Submits IND Application To FDA For Clinical Trial Of Psilocybin-Assisted Psychotherapy In Patients With IBS

Photo: Benzinga edit with photo by cottonbro and Chokniti Khongchum on Pexels.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsPsychedelicsOfferingsLegalManagementMarketsColorado Psychedelicspsilocybin therapies
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.


Loading...